SINTX ANNOUNCES NEW ANTIBACTERIAL BIOMEDICAL PATENTS AND EXPANSION OF INTELLECTUAL PROPERTY PORTFOLIO
October 04 2022 - 11:05AM
SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or
the “Company”), an original equipment manufacturer (OEM) of
advanced ceramic materials for medical and technical applications,
announced today it has been awarded four new international patents
for antibacterial biomedical implants.
Awarded by the countries of Canada, Australia
(two patent awards), and Japan, these patents enhance SINTX’s
portfolio of intellectual property. Silicon Nitride, one of the
premium bioceramics offered by SINTX, has been shown previously to
exhibit the bacteriostatic benefits sought after in medical
implants. These patent awards and the protection they provide
enable SINTX to offer even greater value to medical device partners
operating within the protected geographies.
“At SINTX, we value our intellectual property,
and these awards strengthen our IP portfolio,” said Dr. Ryan Bock,
Vice President of Research and Development, SINTX Technologies.
“The topic of antibacterial protection for medical implants is of
interest across all surgical areas because bacteria and infection
continue to represent some of the most significant issues within
healthcare. SINTX has already received interest in our material
from med-tech companies looking for a way to reduce bacteria issues
associated with their implants.”
Evolving from a spine company, SINTX
Technologies has expanded and diversified significantly through
entering new markets and acquisition. The recent acquisition of
Technology Assessment & Transfer (TA&T) expanded the
Company’s product portfolio into other ceramic materials such as
zirconia and alumina, both for medical and industrial applications.
Today, SINTX is dedicated to the manufacturing, research, and
development of advanced materials science-based solutions to
improve quality of life.
For more information, please visit https://sintx.com/.
About SINTX Technologies, Inc.
SINTX Technologies is an advanced ceramics
company that develops and commercializes materials, components, and
technologies for medical and technical applications. SINTX is a
global leader in the research, development, and manufacturing of
silicon nitride, and its products have been implanted in humans
since 2008. Over the past two years, SINTX has utilized strategic
acquisitions and alliances to enter into new markets. The Company
has manufacturing facilities in Utah and Maryland.
Forward-Looking Statements for SINTX Technologies,
Inc.
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 (PSLRA) that are subject to a number of risks
and uncertainties. Risks and uncertainties that may cause such
differences include, among other things: incorporation of silicon
nitride into medical implants or other products may not result in
bacteriostatic benefits or prove to be commercially viable; the FDA
may not clear any products for commercialization; the industry may
not accept the new products or may turn to products they deem more
effective or less expensive; patients may not realize the expected
benefits of our products; volatility in the price of SINTX’s common
stock; the uncertainties inherent in new product development,
including the cost and time required to commercialize such
product(s); market acceptance of our products once commercialized;
SINTX’s ability to raise additional funding and other competitive
developments. Readers are cautioned not to place undue reliance on
the forward-looking statements, which speak only as of the date on
which they are made and reflect management’s current estimates,
projections, expectations, and beliefs. There can be no assurance
that any of the anticipated results will occur on a timely basis or
at all due to certain risks and uncertainties, a discussion of
which can be found in SINTX’s Risk Factors disclosure in its Annual
Report on Form 10-K, filed with the Securities and Exchange
Commission (SEC) on March 25, 2022, and in SINTX’s other filings
with the SEC. SINTX disclaims any obligation to update any
forward-looking statements. SINTX undertakes no obligation to
publicly revise or update the forward-looking statements to reflect
events or circumstances that arise after the date of this
report.
Business or Media Inquiries for SINTX:
SINTX Technologies801.839.3502IR@sintx.com
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Aug 2024 to Sep 2024
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Sep 2023 to Sep 2024